First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 20,300 followers.

RT @FrontOncology: New research: First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain meta…

09 Feb 2024

Reply Repost Favourite

New research: First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study: Introduction Brain metastases commonly occur in patients with non-small cell lung cancer (NSCLC).… https://t.

09 Feb 2024

Reply Repost Favourite

RT @brownjlauren: Pleased to share our work examining the outcomes of patients receiving immunotherapy for NSCLC and brain metastases, a mu…

07 Feb 2024

Reply Repost Favourite

RT @brownjlauren: Pleased to share our work examining the outcomes of patients receiving immunotherapy for NSCLC and brain metastases, a mu…

07 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.